Co-expression of thymidine kinase and cathepsin D in 200 primary breast carcinomas

Cancer Letters

Volumn 160, Issue 1, 2000, Pages 13-19

  Greco, S ^a   Marsigliante, S ^a   Leo, G ^b   Storelli, C ^a  

^a UNIVERSITY OF SALENTO   (Italy)

^b AO 'V Fazzi' 73100   (Italy)

Author keywords

Breast cancer; Cathepsin D; Steroid receptors; Thymidine kinase

Indexed keywords

CATHEPSIN D; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR; THYMIDINE KINASE;

ARTICLE; BREAST CANCER; CANCER INVASION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; BREAST NEOPLASMS; CARCINOMA, INFILTRATING DUCT; CATHEPSIN D; FEMALE; HUMAN; LYMPH NODES; MENOPAUSE; MIDDLE AGE; NEOPLASM INVASIVENESS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; STATISTICS; THYMIDINE KINASE;

EID: 0034634751     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00550-4     Document Type: Article

References (35)

1. Hannigan B.M., Barnett Y.A., Armstrong D.B., McKelvey-Martin V.J., McKenna P.G. Thymidine kinases: the enzymes and their clinical usefulness. Cancer Biother. 8:1993;189-197.
2. Gronowitz J.S., Kallander F.R., Diderholm H., Hagberg H., Pettersson U. Application of an in vitro assay for serum thymidine kinase: results on viral disease and malignancies in humans. Int. J. Cancer. 33:1984;5-12.
3. Ellims P.H., Eng Gan T., Medley G., Van der Weyden M.B. Prognostic relevance of thymidine kinase isozymes in adult non-Hodgkin's lymphoma. Blood. 58:1981;926-930.
4. Hagberg H., Gronowitz S., Killander A., Kallander C., Simonsson B., Sundstrom C., Oberg G. Serum deoxythymidine kinase in acute leukemia. Br. J. Cancer. 49:1984;537-540.
5. Simonsson B., Kallander C.F.R., Brenning B., Killander A., Ahre A., Gronowitz J.S. Evaluation of serum thymidine kinase as a marker in multiple myeloma. Br. J. Haematol. 61:1985;215-224.
6. Rehn S., Gronowitz J.S., Kallander C., Sundstrom C., Glimelius B. Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas. Br. J. Cancer. 71:1995;1099-1105.
7. Romain S., Christensen J., Chinot O., Balslev I., Rose C., Martin P.M., Thorpe S.M. Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer. Int. J. Cancer. 61:1995;7-12.
8. Romain S., Martin P.M., Klijn J.G., van Putten W.L., Look M.P., Guirou O., Foekens J.A. DNA-synthesis enzyme activity: a biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer? Int. J. Cancer. 74:1997;156-161.
9. Ebuchi M., Sakamoto S., Kudo H., Nagase J., Endo M. Clinicopathological stages and pyrimidine nucleotide synthesis in human mammary carcinomas. Anticancer Res. 15:1995;1481-1484.
10. Bennini N., Mauriac L., Wafflart J., Bonichon F., Durand M. Value of thymidine kinase in the prediction of response to treatment by chemotherapy or hormone therapy in breast cancer. Bull. Cancer. 79:1992;773-779.
11. Kausitz J., Kuliffay P., Pecen L., Eben K., Puterova B. Correlation of cytosolic concentrations of ER, PS2, Cath-D, TPS, TK and camp in primary breast carcinomas. Neoplasma. 41:1994;331-336.
12. Foekens J.A., Look M.P., Bolt-de Vries J., Meijer-van Gelder M.E., van Putten W.L., Klijn J.G. Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. Br. J. Cancer. 79:1999;300-307.
13. Westley B., Rochefort H. Estradiol induced proteins in the MCF7 human breast cancer cell line. Biochem. Biophys. Res. Commun. 90:1979;410-416.
14. Rochefort H., Capony F., Garcia M., Cavailles V., Freiss G., Chambon M., Morisset M., Vignon F. Estrogen-Induced lysosomial proteases secreted by breast cancer cells: a role in carcinogenesis? J. Cell Biochem. 35:1987;17-29.
15. Garcia M., Lacombe M.J., Duplay H., Cavailles V., Derocq D., Delarue J.C., Krebs B., Contesso G., Sancho-Garnier H., Richer G., Domergue J., Namer M., Rochefort H. Immunohistochemical distribution of the 52-KDa protein in mammary tumors: a marker associated with cell proliferation rather than with hormone responsiveness. J. Steroid Biochem. 27:1987;439-445.
16. Hahnel R., Harvey J., Robbins P., Sterrett G. Cathepsin-D in human breast cancer: correlation with vascular invasion and other clinical and histopathological characteristics. Anticancer Res. 13:1993;2131-2135.
17. Rochefort H. Biological and clinical significance of cathepsin D in breast cancer. Acta Oncol. 31:1992;125-130.
18. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathology. 19:1991;403-410.
19. Romain S., Spyratos F., Guirou O., Deytieux S., Chinot O., Martin P.M. Technical evaluation of thymidine kinase assay in cytosols from breast cancers. EORTC Receptor Study Group Report. Eur. J. Cancer, 30A. 1994;2163-2165.
20. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
21. Duffy M.J., O'Siorain L., Waldron B., Smith C. Estradiol receptors in human breast carcinomas assayed by use of monoclonal antibodies. Clin. Chem. 32:1986;1972-1974.
22. O'Neill K.L., McKelvey V.J., Hoper M., Monteverde H., Odling-Smee G.W., Logan H., Abram W.P., McKenna P.G. Breast tumour thymidine kinase levels and disease recurrence. Med. Lab. Sci. 49:1992;244-247.
23. Spyratos F., Martin P.M., Hacene K., Romain S., Andrieu C., Ferrero-Pous M., Deytieux S., Le Doussal V., Tubiana-Hulin M., Brunet M. Multiparametric prognostic evaluation of biological factors in primary breast cancer. J. Natl. Cancer Inst. 84:1992;1266-1272.
24. Romain S., Javre J.L., Samperez S., Jouan P., Bressac C., Varette I., Brandone H., Martin P.M. Prognostic value of thymidine kinase in cancer of the breast. Bull. Cancer. 77:1990;973-983.
25. Kasid A., Davidson N.E., Gelmann E.P., Lippman M.E. Transcriptional control of thymidine kinase gene expression by estrogen and antiestrogens in MCF-7 human breast cancer cells. J. Biol. Chem. 261:1986;5562-5567.
26. Romain S., Chinot O., Guirou O., Soulliere M., Martin P.M. Biological heterogeneity of ER-positive breast cancers in the post-menopausal population. Int. J. Cancer. 59:1994;17-19.
27. Thorpe S.M., Christensen I.J., Rasmussen B.B., Rose C. Short recurrence-free survival associated with high oestrogen receptor levels in the natural history of postmenopausal, primary breast cancer. Eur. J. Cancer, 29A. 1993;971-977.
28. de Larco J.E., Todaro G.J. Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. USA. 75:1978;4001-4005.
29. Derynck R., Roberts A.B., Winkler M.E., Chen E.Y., Goeddel D.V. Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell. 38:1984;287-297.
30. Touitou I., Cavailles V., Garcia M., Defrenne A., Rochefort H. Differential regulation of cathepsin d by sex steroids in mammary cancer and uterine cells. Mol. Cell Endocrinol. 66:1989;231-238.
31. Charpin C., Devictor B., Bonnier P., Andrac L., Lavaut M.N., Allasia C., Piana L. Cathepsin D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors. J. Pathol. 170:1993;463-470.
32. Walker R.A., Dearing S.J. Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas. Breast Cancer Res. Treat. 53:1999;167-176.
33. Mansour O.A., Zekri A.R., Harvey J., el-Ahmady O. Epidermal growth factor receptors: status and effect on breast cancer patients. Anticancer Res. 17:1997;3107-3110.
34. Silverstein M.J., Lewinsky B.S., Waisman J.R., Gierson E.D., Colburn W.J., Senofsky G.M., Gamagami P. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 73:1994;1673-1677.
35. Toikkanen S., Pylkkanen L., Joensuu H. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br. J. Cancer. 76:1997;1234-1240.